7-Methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4(1H)-one

Catalog No. :
ACZOMX387
CAS No. :
1647114-70-2
Molecular Formula :
C15H19BN2O4
Molecular Weight :
302.14

IUPAC Name:7-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4(3H)-one

7-Methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4(1H)-one
IUPAC Name7-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4(3H)-one
Molecular FormulaC15H19BN2O4
Molecular Weight302.14
SMILESO=C1N=CNC2=C1C=C(B3OC(C)(C)C(C)(C)O3)C(OC)=C2
InChI KeyIGWWEHSGGQTBKZ-UHFFFAOYSA-N
Synonym4(3H)-Quinazolinone, 7-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1647114-70-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZOMX387 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACCHDV078 route compound structure diagram
    ACCHDV078950577-05-6 In Stock
  4. Then
  5. ACZOMX387 route product structure diagram
    ACZOMX3871647114-70-2
Inquiry

2. ACZOMX387 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACUXCE925 route compound structure diagram
    ACUXCE925206190-25-2 In Stock
  4. Then
  5. ACZOMX387 route product structure diagram
    ACZOMX3871647114-70-2
Inquiry

Comments (0)